age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
76.67096
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 16
|
>$50k
| 0
| 30,798
| 17,669.5
| 16,483.1094
| 29
|
white
| 19.699219
| 27
| 0.827881
| 0.719971
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 13
| 62
| 11.099609
| 110
| 42
| 39.29688
| 187.5
| 3
| 0.399963
| 2.899902
| 130
| 7.379883
| 234
| 64
| 1,190
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 386
| 0
|
77.31396
|
male
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 58,339
| 35,670.3438
| 28,468.2969
| 33
|
white
| 49.59375
| 84
| 0.007
| 0.001
| 6
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
no dnr
| 16
| 131
| 11.898438
| 160
| 27
| 39
| 222
| null | 0.5
| 1.199951
| 147
| 7.469727
| 127
| 26
| 1,239
| 5
| 6
|
no(M2 and SIP pres)
| 6
| 119
| 1
|
47.41098
|
male
| 0
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 19,594
| null | null | 41
|
white
| 34.5
| 67
| 0.463989
| 0.344971
| 1
| 0
| 0
|
yes
| 0.3
| 0.15
|
no dnr
| 4
| 55
| 3.5
| 150
| 22
| 39.39844
| 135.6875
| 2.399902
| 2.799805
| 1.199951
| 139
| 7.389648
| 106
| 17
| 4,420
| null | null | null | 1.923584
| 183
| 1
|
44.25998
|
male
| 0
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 0
| 183,799
| null | null | 26.5
|
white
| 22.296875
| 18
| 0.849976
| 0.79895
| 8
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 44
| 73
| 14.398438
| 70
| 6
| 38.59375
| 334
| null | null | 1
| 144
| 7.459961
| 126
| 16
| 1,715
| null | null |
no(M2 and SIP pres)
| 2.308106
| 387
| 0
|
29.517
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 19
|
under $11k
| 0
| 72,789
| null | null | 47
|
white
| 37.195313
| 50
| 0.687988
| 0.594971
| 4
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 5
| 97
| 5.699219
| 100
| 20
| 38.89844
| 195.21875
| null | null | 1.599854
| 138
| 7.5
| 137
| 22
| null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
41.90799
|
male
| 1
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 5
| 12
|
$25-$50k
| 0
| 23,213
| null | null | 51
|
white
| 40.5
| 52
| 0.487
| 0.284973
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 5
| 80
| 10.298828
| 70
| 25
| 36.69531
| 96.65625
| 4.699219
| 0.399963
| 1.799805
| 139
| 7.399414
| 145
| 31
| 2,620
| null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
72.56897
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 9
| 12,717
| 6,984.9648
| 6,486.97656
| 17
|
white
| 20.898438
| 25
| 0.803955
| 0.738892
| 1
| 0
| 1
|
no
| 0.5
| 0.3
|
dnr after sadm
| 1
| 72
| 7.299805
| 50
| 28
| 35.29688
| 508
| 3.399902
| 1.599854
| 0.899902
| 141
| 7.459961
| 160
| 28
| 1,420
| null | null |
adl>=4 (>=5 if sur)
| 4.986328
| 384
| 0
|
48.01898
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 3
| 12
|
$25-$50k
| 0
| 23,905
| 12,403.8438
| 3,591.10938
| 14
|
white
| 17.199219
| 14
| 0.741943
| 0.477966
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 69
| 12.798828
| 80
| 24
| 39.09375
| 506.625
| 3.199707
| 0.799927
| 2
| 144
| 7.509766
| 245
| 47
| 3,110
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 116
| 1
|
55.633
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 19,481
| null | null | 13
|
white
| 15.599609
| 10
| 0.754883
| 0.498962
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 116
| 6.199219
| 69
| 22
| 38.19531
| 376.625
| 5.5
| null | 1.099854
| 141
| 6.90918
| 106
| 6
| 8,175
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 384
| 0
|
43.20297
|
male
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
$11-$25k
| 0
| 12,806
| 8,430.7344
| 7,213.02734
| 28
|
white
| 18.5
| 16
| 0.91394
| 0.882935
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 4
| 73
| 5
| 80
| 16
| 36.79688
| null | 4.599609
| 0.899902
| 0.899902
| 140
| null | 111
| 14
| 1,100
| 0
| null | null | 0.494751
| 383
| 0
|
78.00098
|
female
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 56,931
| null | null | 27
|
white
| 27.5
| 30
| 0.638916
| 0.537964
| 5
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 7
| 103
| 7
| 80
| 30
| 38.89844
| 128.3125
| 3.699707
| null | 0.799927
| 137
| 7.319336
| 98
| 9
| 2,400
| null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
77.61298
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 0
| 26,894
| 17,784.5312
| 16,116.2969
| 18
|
black
| 15.5
| 10
| 0.81897
| 0.705933
| 1
| 0
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 11
| 51
| 39.398438
| 80
| 20
| 37
| 121.65625
| null | null | 1.699951
| 144
| 7.479492
| 96
| 50
| 700
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 379
| 0
|
69.24799
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 19,191
| 13,670.2812
| 11,447.1875
| 24
|
white
| 22.199219
| 23
| 0.817993
| 0.755981
| 1
| 0
| 0
|
no
| 0.01
| 0.01
|
dnr after sadm
| 5
| 70
| 12.898438
| 114
| 28
| 38.09375
| 304.75
| 3.099609
| 0.899902
| 0.699951
| 131
| 7.349609
| 189
| 13
| null | null | null |
<2 mo. follow-up
| 2.12793
| 5
| 1
|
59.44699
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 4,928
| null | null | 6
|
white
| 22.5
| 18
| 0.753906
| 0.611938
| 1
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 5
| 100
| null | 70
| 20
| 36.69531
| null | null | null | 0.699951
| 139
| null | 144
| 7
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 334
| 1
|
86.13599
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 59,443
| 42,862.625
| 34,750.9375
| 23.75
|
white
| 40.796875
| 54
| 0.282959
| 0.173981
| 1
| 0
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 26
| 60
| 7.899414
| 130
| 26
| 38
| 353.3125
| null | null | 6.199219
| 134
| 7.389648
| 80
| 43
| 0
| 0
| 0
|
<2 mo. follow-up
| 0
| 40
| 1
|
71.56195
|
female
| 1
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 41
| 31,438
| 23,215.6094
| 18,722.25
| 32.5
|
white
| 25.5
| 49
| 0.598999
| 0.408997
| 1
| 0
| 0
|
no
| 0.5
| 0.7
|
dnr after sadm
| 5
| 107
| 9.699219
| 70
| 20
| 36.09375
| 238.09375
| null | null | 6.099609
| 142
| 7.349609
| 124
| 68
| null | null | 6
|
<2 mo. follow-up
| 6
| 11
| 1
|
81.91895
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 0
| 12,394
| 8,817.6406
| 6,931.17969
| 27
|
white
| 43.695313
| 68
| 0.154999
| 0.074997
| 1
| 1
| 0
|
yes
| 0.1
| 0.01
|
dnr before sadm
| -1
| 70
| 10.898438
| 92
| 50
| 37.09375
| null | null | null | 0.599976
| 136
| null | 81
| 6
| 700
| null | null |
<2 mo. follow-up
| 3.209473
| 6
| 1
|
86.80896
|
female
| 1
| 50
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
$11-$25k
| 0
| 222,569
| null | null | 35.5
|
white
| 25.5
| 52
| 0.691895
| 0.600952
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 39
| 80
| 4.599609
| 80
| 20
| 36.09375
| null | 3.799805
| 0.599976
| 1.5
| 138
| null | 83
| 20
| 1
| 0
| 0
|
<2 mo. follow-up
| 0
| 50
| 1
|
52.76398
|
male
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
| null | 0
| 38,836
| 28,903.2031
| 22,790.8125
| 45
|
white
| 30
| 54
| 0.578979
| 0.468994
| 1
| 0
| 0
|
yes
| 0.05
| 0.01
|
dnr after sadm
| 4
| 106
| 10.099609
| 62
| 54
| 38.19531
| 217.5
| 1
| null | 1.699951
| 139
| 7.389648
| 95
| 38
| 500
| null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
77.42896
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 9
|
under $11k
| 0
| 9,491
| 5,027
| 4,679.55859
| 7.5
|
white
| 16.699219
| 29
| 0.860962
| 0.769897
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 8
| 67
| 21.398438
| 60
| 20
| 36.09375
| 319
| null | 0.199982
| 0.699951
| 142
| 7.479492
| 498
| 32
| 2,100
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 179
| 1
|
74.72998
|
female
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 9
| 24,127
| 21,646.7188
| 16,400.8594
| 32
|
white
| 31.699219
| 76
| 0.577881
| 0.467957
| 1
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 53
| 5.699219
| 60
| 20
| 35.59375
| 266.625
| 3.699707
| 1.699951
| 1.799805
| 144
| 7.449219
| 166
| 92
| null | null | null |
<2 mo. follow-up
| 3.767578
| 9
| 1
|
84.745
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 32,357
| 19,647.4688
| 19,541.6406
| 18.666656
|
white
| 25.296875
| 29
| 0.705933
| 0.61792
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 18
| 122
| 13.298828
| 157
| 38
| 36.09375
| 285
| null | 0.699951
| 0.799927
| 137
| 7.299805
| 209
| 23
| 750
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 107
| 1
|
88.19397
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 9
| 19,104
| 13,220.2812
| 11,556.3984
| 11
|
white
| 25
| 45
| 0.660889
| 0.562988
| 1
| 0
| 1
|
no
| 0.8
| 0.7
|
dnr after sadm
| 3
| 107
| 8.5
| 68
| 24
| 38.5
| 275
| 3.599609
| 0.699951
| 1
| 137
| 7.359375
| 284
| 16
| 1,285
| null | 3
|
no(M2 and SIP pres)
| 3
| 356
| 0
|
67.02295
|
female
| 0
| 53
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 13
| null | 9
| 159,022
| null | null | 19.75
|
white
| 30.5
| 42
| 0.356995
| 0.23999
| 45
| 0
| 0
|
yes
| 0.7
| 0.3
|
dnr after sadm
| 20
| 60
| 14.599609
| 61
| 8
| 38.29688
| 80
| null | null | 1.799805
| 146
| 7.349609
| 121
| 26
| 3,765
| 2
| 1
|
SIP>=30
| 1
| 104
| 1
|
47.45798
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 10
|
under $11k
| 0
| 17,973
| 10,558.2734
| 9,141.5
| 7.5
|
white
| 23.699219
| 38
| 0.872925
| 0.78894
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 7
| 79
| 24.597656
| 71
| 18
| 35.59375
| 362
| 2.099609
| 6.599609
| 1.5
| 152
| 7.419922
| 561
| 45
| 3,585
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 238
| 1
|
76.87097
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 18
|
$11-$25k
| 0
| 5,444
| 3,222.0918
| 3,093.62891
| 7
|
white
| 21.597656
| 26
| 0.80188
| 0.680908
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 113
| 30.699219
| 80
| 16
| 36.19531
| 170
| null | 29.097656
| 7.199219
| 136
| 7.339844
| 85
| 118
| 185
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 352
| 0
|
73.92694
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 9
| 21,820
| 13,192.5547
| 14,935.5547
| 16.5
|
hispanic
| 15.699219
| 18
| 0.862915
| 0.815918
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 8
| 103
| 9.298828
| 60
| 20
| 37.79688
| null | null | null | 1.699951
| 141
| null | 104
| 23
| 5,200
| 0
| 3
|
no(M2 and SIP pres)
| 3
| 351
| 0
|
62.89099
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 12
|
under $11k
| 0
| 4,700
| 2,471.3027
| 2,245.6582
| 6
|
white
| 14
| 13
| 0.899902
| 0.831909
| 1
| 1
| 0
|
yes
| 0.9
| 0.5
|
dnr before sadm
| -1
| 43
| 4.899414
| 64
| 26
| 37.69531
| 176.65625
| null | null | 1.799805
| 135
| 7.439453
| 76
| 33
| 525
| 6
| null |
SIP>=30
| 4.527344
| 348
| 0
|
83.72296
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| null |
under $11k
| 0
| 11,448
| 5,841.5977
| 4,862.32812
| 8.5
|
white
| 18.898438
| 26
| 0.768921
| 0.632935
| 1
| 0
| 0
|
yes
| 0.95
| 0.5
|
no dnr
| 8
| 80
| 9.398438
| 50
| 20
| 36.09375
| null | null | null | 1.5
| 142
| null | 76
| 31
| 1,450
| 0
| 0
| null | 0
| 347
| 0
|
73.15796
|
male
| 1
| 17
|
Lung Cancer
|
Cancer
| 1
| 8
|
$11-$25k
| 9
| 30,549
| 15,945.3047
| 15,568.4141
| 13.333328
|
white
| 20.097656
| 9
| 0.578979
| 0.258972
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 14
| 100
| 17.199219
| 130
| 40
| 35.89844
| 131.65625
| 2.099609
| null | 0.799927
| 137
| 7.5
| 178
| 22
| 700
| 2
| 1
|
<2 mo. follow-up
| 1
| 17
| 1
|
97.59595
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 20
|
>$50k
| 0
| 6,900
| 3,685.7031
| 3,522.57812
| 11
|
white
| 15.199219
| 26
| 0.767944
| 0.630981
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 1
| 130
| 4.399414
| 80
| 20
| 37.79688
| null | null | null | 5.199219
| 143
| null | 118
| 50
| 950
| null | null |
adl>=4 (>=5 if sur)
| 4.043945
| 247
| 1
|
84.67596
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$11-$25k
| 0
| 123,202
| null | null | 26
|
white
| 21.796875
| 36
| 0.75293
| 0.674927
| 2
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 29
| 113
| 14.898438
| 80
| 25
| 36.09375
| 138.3125
| null | null | 3.799805
| 145
| 7.439453
| 117
| 72
| 950
| 2
| 0
|
no(M2 and SIP pres)
| 0
| 344
| 0
|
81.06995
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 9
| 29,290.906
| 16,614.9375
| null | 40
|
white
| 31.398438
| 61
| 0.349976
| 0.232971
| 13
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr before sadm
| 0
| 115
| 24
| 142
| 36
| 37.69531
| 143.3125
| 2.5
| 0.799927
| 1.5
| 155
| 7.389648
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 5
| 1
|
78.10797
|
male
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 37
| 59,070.875
| 33,565.2812
| null | 34
|
black
| 26.398438
| 57
| 0.422974
| 0.302979
| 4
| 0
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 14
| 107
| 6.399414
| 118
| 26
| 38.5
| 260
| 1.899902
| 4.699219
| 2
| 139
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
66.16595
|
female
| 1
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 20
|
$11-$25k
| 0
| 204,219.875
| 112,552.25
| null | 49.5
|
black
| 25.597656
| 35
| 0.711914
| 0.623901
| 13
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 34
| 117
| 10
| 110
| 8
| 39
| 290
| null | null | 3.5
| 134
| 7.429688
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 35
| 1
|
27.76199
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 44
| 70,693.625
| 40,952.1562
| null | 52
|
black
| 48.195313
| 88
| 0.246979
| 0.143982
| 1
| 0
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 16
| 60
| 13.699219
| 152
| 12
| 35.69531
| 76.65625
| 1.599854
| 13.099609
| 3.599609
| 132
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
71.29095
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 15,564.695
| 9,390.3203
| null | 18
|
white
| 16
| 25
| 0.875
| 0.791992
| 2
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 12
| 80
| 8.199219
| 80
| 22
| 36.5
| 226.65625
| null | null | 1.599854
| 137
| 7.459961
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 744
| 1
|
63.67099
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 9
|
under $11k
| 0
| 5,074.648
| 3,149.7344
| null | 11
|
white
| 33.398438
| 35
| 0.27594
| 0.040993
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 87
| 26
| 108
| 36
| 37.69531
| 314.25
| 2.399902
| 0.399963
| 0.799927
| 139
| 7.479492
| null | null | null | 2
| 4
| null | 4
| 70
| 1
|
42.09698
|
male
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 44
| 65,025.031
| 35,397.4062
| null | 62.5
|
white
| 43.195313
| 92
| 0.007999
| 0.001
| 11
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
no dnr
| 9
| 63
| 0.199982
| 145
| 28
| 37.89844
| 242.84375
| 2
| 5.199219
| 4.099609
| 161
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 2.985352
| 9
| 1
|
66.30499
|
female
| 1
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$11-$25k
| 37
| 182,129.875
| 103,131.188
| null | 45
|
white
| 24
| 37
| 0.688965
| 0.596924
| 1
| 0
| 0
|
no
| 0.7
| 0.75
|
dnr after sadm
| 31
| 93
| 18.796875
| 100
| 10
| 38.5
| 203.3125
| 2
| 1
| 3.099609
| 138
| 7.369141
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 43
| 1
|
29.33299
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
| null | 0
| 48,388.219
| 28,524.0625
| null | 35.333313
|
white
| 24.699219
| 48
| 0.892944
| 0.85498
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 20
| 62
| 27.796875
| 62
| 16
| 38.79688
| 118.45312
| 1.899902
| 3
| 0.899902
| 140
| 7.449219
| null | null | null | null | 0
| null | 0
| 2,026
| 0
|
48.87097
|
male
| 0
| 14
|
Colon Cancer
|
Cancer
| 1
| 17
|
>$50k
| 0
| 13,197.648
| 7,754.8945
| null | 13.666664
|
white
| 25.597656
| 15
| 0.710938
| 0.429993
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
no dnr
| 14
| 101
| 5.199219
| 95
| 18
| 38.5
| null | 2.399902
| 0.199982
| 0.899902
| 137
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 207
| 1
|
71.81696
|
female
| 0
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
| null | 0
| 11,220.297
| 8,075.2109
| null | 11
|
black
| 24.5
| 36
| 0.779907
| 0.648926
| 1
| 0
| 0
|
no
| 1
| 0.8
|
dnr after sadm
| 2
| 130
| 5.799805
| 60
| 26
| 35.5
| 509.5
| 2.799805
| 0.5
| 1.5
| 139
| 7.379883
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 24
| 1
|
63.48297
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 0
| 18
|
>$50k
| 0
| 3,371.1
| 2,288.6973
| null | 6
|
white
| 19
| 9
| 0.790894
| 0.559937
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 6
| 83
| 4.699219
| 72
| 24
| 36.69531
| null | 3
| 0.5
| 0.899902
| 139
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,162
| 1
|
60.939
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 7
|
$11-$25k
| 0
| 4,007.6
| 2,527.5527
| null | 7
|
black
| 13.599609
| 6
| 0.921997
| 0.868896
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 4
| 97
| 5.599609
| 80
| 20
| 36.59375
| null | null | null | 1
| 139
| null | null | null | null | 1
| 3
|
no(M2 and SIP pres)
| 3
| 455
| 1
|
74.52399
|
female
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 5,275.547
| 3,996.9512
| null | 7
|
white
| 13.099609
| 18
| 0.900879
| 0.832886
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 12
| 87
| 3.899902
| 65
| 20
| 35.89844
| null | 4.099609
| 0.899902
| 1.199951
| 144
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 891
| 1
|
50.42599
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 2,317.148
| 1,679.041
| null | 1
|
white
| 18.796875
| 19
| 0.851929
| 0.756958
| 1
| 0
| 0
|
no
| 0.98
| 0.8
|
no dnr
| 5
| 96
| 5.299805
| 82
| 20
| 37.09375
| null | 2.599609
| 5.399414
| 0.899902
| 133
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,753
| 1
|
45.91098
|
female
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 3,229.148
| 2,311.6875
| null | 5.5
|
white
| 16.796875
| 30
| 0.859985
| 0.768921
| 1
| 0
| 0
|
yes
| 0.98
| 0.9
|
no dnr
| 7
| 69
| 4.099609
| 60
| 16
| 37.39844
| null | 2.299805
| 2.099609
| 1.399902
| 135
| null | null | null | null | 0
| 5
|
no(M2 and SIP pres)
| 5
| 85
| 1
|
33.73297
|
female
| 0
| 32
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 10
|
under $11k
| 0
| 65,649.062
| 43,195.5
| null | 20.75
|
white
| 20.097656
| 15
| 0.927979
| 0.876953
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 32
| 77
| 20.398438
| 110
| 16
| 37.09375
| 328
| null | 0.399963
| 0.699951
| 138
| 7.429688
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 2,021
| 0
|
46.77899
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
$11-$25k
| 94
| 18,037.5
| 9,498.8984
| null | 28
|
white
| 21.097656
| 13
| 0.608887
| 0.50293
| 2
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 85
| 22.398438
| 130
| 14
| 39.09375
| 432.5
| 3.799805
| 0.699951
| 0.899902
| 137
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 6
| 1
|
49.85098
|
male
| 1
| 23
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 11
| null | 44
| 70,955.75
| 41,781.0625
| null | 33.333313
|
white
| 27.699219
| 39
| 0.315979
| 0.202972
| 14
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 8
| 67
| 1.399902
| 112
| 25
| 37.39844
| 300
| 2.099609
| 1.399902
| 0.699951
| 142
| 7.469727
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 23
| 1
|
50.82797
|
female
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null |
under $11k
| 0
| 12,101.797
| 7,537.4258
| null | 14
|
white
| 24.898438
| 32
| 0.716919
| 0.559937
| 6
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 6
| 91
| 10.099609
| 125
| 22
| 36.89844
| null | null | 2.899902
| 1.899902
| 136
| null | null | null | null | 0
| 0
|
SIP>=30
| 0
| 2,020
| 0
|
68.01398
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 1
| null | 0
| 68,718.562
| 37,504.25
| null | 45.666657
|
other
| 28.199219
| 39
| 0.68396
| 0.590942
| 4
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 17
| 90
| 18.296875
| 100
| 10
| 37.29688
| 147.5
| 2.699707
| 0.5
| 3.199707
| 137
| 7.429688
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 17
| 1
|
62.67999
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 5,012.098
| 3,631.3223
| null | 5.5
|
white
| 17.097656
| 29
| 0.893921
| 0.822998
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 10
| 63
| 7
| 100
| 24
| 36.19531
| 319
| 3.799805
| 0.699951
| 1.599854
| 137
| 7.479492
| null | null | null | 0
| 0
| null | 0
| 248
| 1
|
54.543
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 119,274.125
| 68,801.75
| null | 31
|
white
| 25
| 45
| 0.827881
| 0.768921
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 35
| 109
| 16.5
| 118
| 40
| 38.79688
| 176.34375
| 1.399902
| 0.199982
| 0.799927
| 136
| 7.389648
| null | null | null | null | 2
| null | 2
| 472
| 1
|
82.62
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 0
| 123,505.188
| 67,257.9375
| null | 35.5
|
white
| 36.5
| 55
| 0.303955
| 0.191986
| 27
| 0
| 0
|
no
| null | null |
dnr after sadm
| 6
| 73
| 30
| 110
| 11
| 35.89844
| 116.65625
| 2.799805
| 0.799927
| 3.399902
| 151
| 7.319336
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
54.55399
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 14,758.742
| 8,782.7109
| null | 19
|
black
| 18.296875
| 23
| 0.901978
| 0.835938
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 90
| 7.799805
| 104
| 32
| 36.59375
| null | null | null | 1.099854
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 2,015
| 0
|
48.827
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 9
| 24,232.469
| 14,970.9062
| null | 28
|
white
| 24.796875
| 40
| 0.825928
| 0.767944
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 14
| 60
| 16.398438
| 108
| 24
| 37.5
| 368
| 1.699951
| 1.799805
| 2.799805
| 140
| 7.389648
| null | null | null | 1
| 1
|
SIP>=30
| 1
| 2,015
| 0
|
42.41498
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 100
| 26,228.594
| 14,142.5312
| null | 54
|
white
| 56.59375
| 96
| 0
| 0
| 6
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 47
| 16.5
| 200
| 34
| 39
| 74
| 2.599609
| 30.5
| 6.199219
| 141
| 7.229492
| null | null | null | null | null |
<2 mo. follow-up
| 2.881348
| 5
| 1
|
70.01196
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 2,736.148
| 1,958.3613
| null | 11
|
black
| 16.5
| 15
| 0.87793
| 0.797974
| 1
| 0
| 0
|
no
| 1
| 0.8
|
no dnr
| 5
| 113
| 13.099609
| 70
| 20
| 36.19531
| 252.375
| null | null | 1.099854
| 138
| 7.479492
| null | null | null | null | null | null | 3.185547
| 1,781
| 1
|
60.34497
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 5,197.066
| 3,336.3731
| null | 8
|
white
| 14.199219
| 29
| 0.925903
| 0.873901
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 7
| 99
| 7.399414
| 90
| 28
| 37.09375
| 194.375
| 4.099609
| 0.5
| 0.799927
| 144
| 7.369141
| null | null | null | 2
| 3
|
no(M2 and SIP pres)
| 3
| 1,761
| 1
|
55.98898
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 6,171.199
| 3,968.0488
| null | 10
|
white
| 19.796875
| 19
| 0.886963
| 0.810913
| 1
| 1
| 0
|
no
| 1
| 0.99
|
no dnr
| 6
| 108
| 10.699219
| 126
| 18
| 37.29688
| null | null | null | 1
| 144
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 2,015
| 0
|
42.89099
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 4,847.797
| 2,779.7148
| null | 12
|
white
| 17.699219
| 19
| 0.92688
| 0.875977
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 4
| 77
| 8.599609
| 94
| 16
| 36.5
| null | null | null | 1.699951
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,380
| 1
|
26.407
|
female
| 1
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 9
| null | null | null | 33.333313
|
black
| 44.296875
| 84
| 0.363953
| 0.171997
| 30
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 15
| 52
| 52
| 82
| 25
| 36.89844
| 285.6875
| 2.299805
| 44.09375
| 5
| 139
| 7.389648
| null | null | null | 6
| null |
<2 mo. follow-up
| 4.527397
| 15
| 1
|
55.13797
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 4,260.598
| 2,585.875
| null | 10
|
white
| 24.597656
| 18
| 0.55896
| 0.237
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 5
| 73
| 9.798828
| 84
| 12
| 38.5
| null | 2.699707
| 0.199982
| 0.599976
| 139
| null | null | null | null | 0
| 4
| null | 4
| 65
| 1
|
37.65399
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 17
|
$25-$50k
| 0
| 25,829.297
| 14,263.2422
| null | 14
|
other
| 14
| 5
| 0.889893
| 0.748901
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 7
| 91
| 4.399414
| 86
| 20
| 37.59375
| null | null | 0.299988
| 0.699951
| 144
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 21
| 1
|
64.323
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 3,637.6
| 2,708.7031
| null | 10
|
black
| 24.597656
| 34
| 0.80896
| 0.690918
| 1
| 1
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 8
| 110
| 23.199219
| 100
| 16
| 36.59375
| 270
| null | 0.199982
| 5.199219
| 144
| 7.339844
| null | null | null | 1
| null | null | 1.1669
| 2,013
| 0
|
58.21198
|
female
| 1
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 100
| 14,696.945
| 8,260.25
| null | 32
|
white
| 59
| 104
| 0
| 0
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 37
| 34.296875
| 35
| 12
| 35.79688
| 261
| 2.399902
| 8.798828
| 3
| 122
| 7.269531
| null | null | null | null | null |
<2 mo. follow-up
| 3.397949
| 3
| 1
|
71.31799
|
male
| 1
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 25,847.641
| 15,369.0859
| null | 24
|
black
| 18.597656
| 25
| 0.850952
| 0.754883
| 1
| 0
| 0
|
no
| 1
| 0.8
|
no dnr
| 14
| 102
| 11.298828
| 88
| 28
| 36.5
| 229.15625
| null | null | 0.799927
| 146
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 3.169922
| 14
| 1
|
69.79095
|
male
| 0
| 35
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 50,310.688
| 30,847.0469
| null | 16
|
white
| 18.296875
| 28
| 0.865967
| 0.778931
| 1
| 0
| 0
|
no
| null | 0.5
|
no dnr
| 35
| 63
| null | 70
| 20
| 35.09375
| 566.625
| null | null | 1.299805
| 137
| 7.399414
| null | null | null | null | null | null | 3.318848
| 296
| 1
|
69.92694
|
female
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 37
| 82,018.938
| 47,612.4375
| null | 46
|
white
| 32.09375
| 57
| 0.461975
| 0.342957
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 21
| 113
| 19.597656
| 65
| 27
| 35
| 147.5
| 1.699951
| 0.199982
| 2.899902
| 135
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 21
| 1
|
44.35599
|
female
| 0
| 136
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 26
| 336,191.75
| 191,845.5
| null | 32.75
|
white
| 31.097656
| 47
| 0.587891
| 0.478943
| 28
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 136
| 130
| 20.398438
| 100
| 10
| 36.89844
| 170
| 3.899902
| 12.599609
| 1.299805
| 138
| 7.479492
| null | null | null | 2
| 0
|
SIP>=30
| 0
| 2,009
| 0
|
46.83899
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 4,346.148
| 3,380.3809
| null | 3
|
white
| 17.199219
| 19
| 0.92395
| 0.870972
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 71
| 6
| 68
| 24
| 36.59375
| 357.125
| null | 1.099854
| 1.799805
| 141
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 2,009
| 0
|
65.28998
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 115,224.25
| 67,811.125
| null | 18
|
black
| 23.898438
| 20
| 0.563965
| 0.451965
| 26
| 0
| 0
|
no
| null | null |
no dnr
| 29
| 83
| 22.699219
| 110
| 26
| 38
| 463.3125
| 3.399902
| null | 0.599976
| 152
| 7.479492
| null | null | null | null | null | null | 3.089356
| 2,008
| 0
|
69.05396
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 11
|
$11-$25k
| 0
| null | null | null | 7
|
white
| 18.796875
| 25
| 0.862915
| 0.772949
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 5
| 73
| 7
| 68
| 20
| 35.39844
| null | null | null | 1.5
| 143
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 132
| 1
|
18.946
|
male
| 1
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 9
| null | 9
| 61,863.156
| 34,996.3438
| null | 43
|
black
| 36
| 63
| 0.339966
| 0.223999
| 7
| 0
| 0
|
yes
| 0.4
| 0.4
|
dnr after sadm
| 9
| 110
| 0.099991
| 110
| 29
| 37.79688
| 137.125
| 1.599854
| 1.399902
| 0.5
| 146
| 7.40918
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 12
| 1
|
23.573
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 0
| 63,657.625
| 36,136.1562
| null | 45
|
white
| 36.59375
| 56
| 0.68396
| 0.590942
| 23
| 0
| 0
|
no
| 0
| 0
|
no dnr
| 7
| 110
| 0.199982
| 184
| 26
| 39.29688
| 128.875
| null | 0.199982
| 0.799927
| 134
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
71.07996
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 16
|
under $11k
| 0
| 10,907.797
| 8,287.3438
| null | 13.666664
|
hispanic
| 18
| 35
| 0.86499
| 0.775879
| 1
| 1
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 3
| 63
| 5.099609
| 89
| 16
| 37.29688
| 223.78125
| null | 1.199951
| 1.099854
| 128
| 7.509766
| null | null | null | 6
| 4
|
SIP>=30
| 4
| 487
| 1
|
73.40198
|
male
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 11
|
$11-$25k
| 26
| 80,833.062
| 46,143.8125
| null | 43
|
white
| 43.695313
| 86
| 0.019997
| 0.004
| 30
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr after sadm
| 10
| 137
| 1.799805
| 140
| 30
| 39.19531
| 146.65625
| 1.299805
| 13.199219
| 2.299805
| 139
| 7.399414
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 11
| 1
|
61.599
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 100
| 20,699.797
| 13,587.9766
| null | 43
|
white
| 39.398438
| 59
| 0.052994
| 0.016998
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 3
| 48
| 11.099609
| 118
| 12
| 36.69531
| 227.5
| 2.299805
| 5.799805
| 4.099609
| 138
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 3.058106
| 4
| 1
|
39.31
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 13
| null | 0
| 32,710.188
| 20,681.2969
| null | 17.5
|
black
| 31.699219
| 44
| 0.728882
| 0.644897
| 8
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 1
| 94
| 21.699219
| 120
| 24
| 37.29688
| 363.3125
| null | 8.798828
| 1.899902
| 132
| 7.359375
| null | null | null | 2
| 3
|
<2 mo. follow-up
| 3
| 11
| 1
|
62.26398
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 13
|
$25-$50k
| 0
| 4,991.348
| 3,246.8242
| null | 15
|
white
| 21
| 17
| 0.62793
| 0.315979
| 1
| 0
| 0
|
metastatic
| 1
| 0.6
|
no dnr
| 5
| 127
| 5.399414
| 115
| 20
| 36
| null | null | null | 0.799927
| 135
| null | null | null | null | 0
| 0
| null | 0
| 63
| 1
|
78.93799
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 11,457.445
| 8,526.6406
| null | 10.5
|
white
| 16.199219
| 24
| 0.691895
| 0.40094
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 12
| 87
| 7.199219
| 68
| 32
| 39
| null | null | null | 1.099854
| 133
| null | null | null | null | null | null | null | 3.381836
| 435
| 1
|
67.745
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 3
| 12
| null | 0
| 7,447.699
| 5,835.6016
| null | 12
|
white
| 34.09375
| 35
| 0.43396
| 0.125977
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.1
|
no dnr
| 7
| 110
| 6.5
| 72
| 16
| 36.79688
| null | 1.899902
| null | 1.699951
| 137
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 23
| 1
|
59.45499
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
|
under $11k
| 0
| 14,134.297
| 10,915.0625
| null | 12.5
|
white
| 33.09375
| 56
| 0.613892
| 0.426941
| 7
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 11
| 58
| 12.699219
| 120
| 28
| 37.29688
| null | null | null | 2.199707
| 124
| null | null | null | null | 1
| 2
|
<2 mo. follow-up
| 2
| 25
| 1
|
72.91998
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 0
| null | null | null | 43.5
|
white
| 32.195313
| 51
| 0.61499
| 0.508911
| 1
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 3
| 132
| 16.597656
| 116
| 25
| 38.5
| 98.875
| null | 0.5
| 1.799805
| 150
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
78.35699
|
male
| 1
| 4
|
Coma
|
Coma
| 0
| null |
under $11k
| 0
| 29,703.188
| 19,801.1094
| null | 49
|
white
| 44.898438
| 73
| 0.049995
| 0.025997
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 4
| 63
| 32.59375
| 110
| 14
| 39.09375
| 110
| 2
| 10
| 5.199219
| 127
| 7.349609
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
59.13797
|
female
| 1
| 5
|
Coma
|
Coma
| 1
| 11
|
under $11k
| 61
| 10,753.492
| 7,511.3359
| null | 17
|
black
| 21.296875
| 33
| 0.516968
| 0.445984
| 2
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 2
| 110
| 18.699219
| 72
| 32
| 38.19531
| 225
| null | null | 1.5
| 163
| 7.469727
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 5
| 1
|
64.98596
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 32,710.891
| 19,770.6406
| null | 23.5
|
white
| 23.296875
| 27
| 0.822998
| 0.711914
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 11
| 53
| 6.599609
| 50
| 22
| 36.39844
| null | null | null | 1.399902
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,118
| 1
|
90.75397
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 2,153.648
| 1,880.4893
| null | 12
|
black
| 23.199219
| 34
| 0.710938
| 0.55188
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 115
| 1.699951
| 76
| 18
| 34.89844
| null | 2.699707
| 0.299988
| 0.799927
| 146
| null | null | null | null | 4
| 2
|
no(M2 and SIP pres)
| 2
| 211
| 1
|
69.48895
|
female
| 0
| 70
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 5
|
$11-$25k
| 0
| 114,818.812
| 70,177.6875
| null | 21.25
|
white
| 32.398438
| 43
| 0.525879
| 0.41095
| 17
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 70
| 117
| 10.298828
| 135
| 40
| 38.59375
| 118.32812
| null | null | 0.599976
| 132
| 7.459961
| null | null | null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 1,999
| 0
|
71.29095
|
female
| 0
| 90
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 0
| 117,566.938
| 84,900.625
| null | 24.5
|
black
| 34.796875
| 69
| 0.475952
| 0.357971
| 1
| 1
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 90
| 55
| 42.898438
| 59
| 8
| 36
| 276.625
| 2.299805
| 6.5
| 5.699219
| 134
| 7.379883
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 105
| 1
|
69.30597
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 12,514.547
| 9,179.7188
| null | 12
|
white
| 17.898438
| 24
| 0.870972
| 0.786987
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 10
| 84
| 7.199219
| 96
| 30
| 37
| 385.6875
| null | null | 1.5
| 139
| 7.479492
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 58
| 1
|
44.31998
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 9
| 34,999.438
| 24,712.7969
| null | 25.666656
|
black
| 28.097656
| 36
| 0.795898
| 0.728882
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 14
| 87
| 12.199219
| 120
| 25
| 38.59375
| 125.45312
| 2.399902
| 1.699951
| 0.799927
| 140
| 7.489258
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.176758
| 1,997
| 0
|
33.85098
|
male
| 0
| 22
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 36,510.125
| 26,459.3594
| null | 17
|
white
| 16.597656
| 11
| 0.819946
| 0.759888
| 4
| 0
| 0
|
yes
| 0.9
| 0.7
|
no dnr
| 22
| 79
| 7.699219
| 60
| 10
| 36.29688
| 284.4375
| null | 0.599976
| 1
| 151
| 7.459961
| null | null | null | null | null | null | 1.698242
| 152
| 1
|
51.67697
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 5,212.348
| 3,679.1934
| null | 9
|
white
| 21.199219
| 12
| 0.782959
| 0.544922
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.25
|
no dnr
| 4
| 63
| 4
| 68
| 18
| 37.39844
| null | 3
| 0.899902
| 0.599976
| 144
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,995
| 0
|
82.086
|
female
| 1
| 21
|
Coma
|
Coma
| 1
| 10
|
under $11k
| 100
| 13,969.148
| 11,240.9141
| null | 6
|
black
| 14.298828
| 22
| 0.310974
| 0.23999
| 1
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 1
| 103
| 7.099609
| 80
| 16
| 36.79688
| 263.25
| null | null | 1.299805
| 144
| 7.379883
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 21
| 1
|
40.05197
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 17
|
under $11k
| 0
| 10,388.547
| 7,787.3867
| null | 10
|
other
| 21
| 21
| 0.887939
| 0.812988
| 7
| 1
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 4
| 80
| 11.599609
| 88
| 16
| 37
| null | null | null | 1.799805
| 130
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 116
| 1
|
43.129
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 32,229.891
| 23,546.1875
| null | 25.666656
|
white
| 19.5
| 13
| 0.906982
| 0.873901
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 15
| 80
| 12.898438
| 110
| 8
| 36.89844
| 340
| null | 0.699951
| 1.199951
| 142
| 7.479492
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 1,994
| 0
|
69.35498
|
female
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
$11-$25k
| 0
| 34,208.688
| 20,752.0156
| null | 19
|
white
| 14.5
| 25
| 0.899902
| 0.832886
| 1
| 1
| 0
|
no
| 0.98
| 0.9
|
no dnr
| 12
| 97
| 6.5
| 60
| 28
| 36.79688
| null | 3.799805
| 0.599976
| 1.099854
| 136
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,994
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.